Navigo Invest Q2 2025: Weaker than expected, though Vinga’s margins remained decent - Redeye

Redeye provides its initial take on Navigo’s Q2 2025 report, which came in broadly below our estimates. We judge that positives from the report include Vinga maintaining decent profitability despite lower-than-expected sales, continued growth for Chemgroup, and solid cash flow. Notable negatives include a clear top-line miss for Vinga and soft profitability for Chemgroup.

Länk till analysen i sin helhet: https://www.redeye.se/research/1123783/navigo-invest-q2-2025-weaker-than-expected-though-vingas-margins-remained-decent?utm_source=finwire&utm_medium=RSS